Bengaluru startup Dognosis is developing BreathEasy, a non-invasive cancer-screening system that combines trained dogs with statistical modeling and machine-learning tools. A published Phase II study found sensitivity and specificity above 90%, but the product remains a triage test under validation rather than an approved cancer diagnosis.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.